 | Gilead Sciences (GILD) Receiving Somewhat Negative Press Coverage, Study Finds
www.americanbankingnews.com - November 20 at 7:26 AM |
 | Gilead’s Vemlidy for chronic hepatitis B virus approved in China
seekingalpha.com - November 19 at 3:01 PM |
 | China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection
finance.yahoo.com - November 19 at 5:03 AM |
| Gilead Sciences' (GILD) "Hold" Rating Reiterated at Oppenheimer
www.americanbankingnews.com - November 15 at 3:26 PM |
| Gilead Sciences (GILD) Stock Rating Reaffirmed by Needham & Company LLC
www.americanbankingnews.com - November 14 at 4:28 PM |
| Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27
finance.yahoo.com - November 13 at 5:07 AM |
| Gilead Sciences, Inc. (GILD) Expected to Announce Quarterly Sales of $5.52 Billion
www.americanbankingnews.com - November 13 at 2:30 AM |
| Gilead Sciences, Inc. (GILD) Expected to Post Earnings of $1.74 Per Share
www.americanbankingnews.com - November 11 at 5:22 PM |
| Somewhat Positive Press Coverage Very Likely to Affect Gilead Sciences (GILD) Stock Price
www.americanbankingnews.com - November 10 at 7:54 PM |
 | Gilead Sciences (GILD) Presents Latest Data from Viral Hepatitis Research Programs at The Liver Meeting
www.streetinsider.com - November 10 at 5:15 AM |
| Gilead Sciences (GILD) Announces Positive Phase 2 Results for GS-9674 in Primary PSC at The Liver Meeting
www.streetinsider.com - November 10 at 5:15 AM |
| Gilead's GS-9674 shows positive action in mid-stage NASH study
seekingalpha.com - November 9 at 3:14 PM |
| Gilead Presents Data From Nonalcoholic Steatohepatitis (NASH) Development Program for Advanced Fibrosis at The Liver Meeting® 2018
finance.yahoo.com - November 9 at 3:14 PM |
| Gilead Announces Positive Phase 2 Results for GS-9674 in Primary Sclerosing Cholangitis (PSC) at The Liver Meeting® 2018
finance.yahoo.com - November 9 at 3:14 PM |
| Gilead Presents Latest Data from Viral Hepatitis Research Programs at The Liver Meeting® 2018
finance.yahoo.com - November 9 at 3:14 PM |
| Is Gilead Sciences Inc’s (NASDAQ:GILD) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - November 8 at 3:18 PM |
| Biotech Analysis Central Pharma News: Gilead's Push, AcelRx's Approval, Trevena's Rejection
seekingalpha.com - November 7 at 3:15 PM |
| Exclusive: Small Peninsula city rejects developer's housing plan — and tells it to go bigger
finance.yahoo.com - November 6 at 5:00 AM |
| John C. Martin Sells 50,000 Shares of Gilead Sciences, Inc. (GILD) Stock
www.americanbankingnews.com - November 5 at 10:14 PM |
 | Why Gilead Sciences, Inc. Stock Broke Down in October
www.fool.com - November 5 at 11:55 AM |
| Gilead Sciences (GILD) Earning Somewhat Favorable Media Coverage, Analysis Finds
www.americanbankingnews.com - November 5 at 3:12 AM |
| Gilead Sciences’ Operational Performance
finance.yahoo.com - November 2 at 3:06 PM |
| What Does Gilead Sciences’ Bottom-Line Trend Indicate?
finance.yahoo.com - November 2 at 3:06 PM |
| Gilead Sciences: An Update for Investors
finance.yahoo.com - November 2 at 3:06 PM |
| Gilead Stock to Jump Double Digits: Morgan Stanley
finance.yahoo.com - November 2 at 3:06 PM |
| Gilead Sciences Is Sporting a Bearish Set of Charts for Investors
finance.yahoo.com - November 2 at 3:06 PM |
| Decatur-based task force becoming ground zero for global elimination of hepatitis B and C
finance.yahoo.com - November 2 at 5:07 AM |
| Raymond James Reaffirms Buy Rating for Gilead Sciences (GILD)
www.americanbankingnews.com - November 1 at 1:22 PM |
| Gilead Sciences (GILD) Given a $94.00 Price Target by Mizuho Analysts
www.americanbankingnews.com - November 1 at 9:39 AM |
 | Investor Expectations to Drive Momentum within Gilead Sciences, SCANA, Brink's, Fortive, Asbury Automotive Group ...
globenewswire.com - November 1 at 5:08 AM |
| Gilead Remains A Sell
seekingalpha.com - November 1 at 5:08 AM |
| Jerome Dodson Comments on Gilead Sciences
finance.yahoo.com - November 1 at 5:08 AM |
| Gilead Sciences' (GILD) "Buy" Rating Reaffirmed at Evercore ISI
www.americanbankingnews.com - October 31 at 3:27 PM |
 | SPTM, TXN, GILD, LMT: Large Inflows Detected at ETF
www.nasdaq.com - October 31 at 3:09 PM |
| Gilead teams up with Tango Therapeutics in cancer
seekingalpha.com - October 31 at 3:09 PM |
| Gilead down 6% as investors unmoved with Tango deal
seekingalpha.com - October 31 at 3:09 PM |
| Gilead shares drop after new UnitedHealth program incentivizes cheaper HIV meds
finance.yahoo.com - October 31 at 3:09 PM |
| Gilead's Biktarvy on par with DTG+FTC/TAF in late-stage HIV study
seekingalpha.com - October 30 at 3:06 PM |
| Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy
finance.yahoo.com - October 30 at 3:06 PM |
| Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2
finance.yahoo.com - October 29 at 3:01 PM |
| Gilead: More Of The Same
seekingalpha.com - October 29 at 9:35 AM |
| How Did Gilead Sciences Fare in the Third Quarter?
finance.yahoo.com - October 29 at 9:35 AM |
| Gilead Sciences, Inc. (GILD) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - October 28 at 12:30 PM |
| Critical Survey: Gilead Sciences (GILD) vs. Solid Biosciences (SLDB)
www.americanbankingnews.com - October 27 at 12:10 PM |
| Gilead Sciences, Inc. (GILD) Short Interest Update
www.americanbankingnews.com - October 27 at 2:38 AM |
| Mizuho Reiterates $94.00 Price Target for Gilead Sciences (GILD)
www.americanbankingnews.com - October 26 at 7:04 PM |
| Gilead Sciences (GILD) PT Raised to $95.00 at Barclays
www.americanbankingnews.com - October 26 at 4:55 PM |
 | Gilead Sciences Stock Is Back to Base — Go Long
investorplace.com - October 26 at 4:49 PM |
| Gilead Sciences (GILD) Price Target Cut to $94.00 by Analysts at Raymond James
www.americanbankingnews.com - October 26 at 4:31 PM |
 | Amazon Tumbles, Gilead Slumps as S&P 500 Eyes Correction
www.barrons.com - October 26 at 3:09 PM |
